Population Health
DeepHealth Brain
Assess and monitor neurodegenerative changes with quantitative and reference data
DeepHealth Brain is an AI-powered clinical imaging solution for brain atrophy quantification and white
matter hyperintensities (WMH) detection. It supports the assessment and monitoring of neurodegenerative
changes with quantitative and reference data. FDA-cleared and CE-marked, DeepHealth Brain seamlessly
integrates into existing workflows, with results, reports, and segmentations exported directly to PACS.
It offers flexible deployment options, including on-site or cloud-based installation.
Brain atrophy analysis
WMH analysis
Comprehensive reports
Automated segmentation
Learn more
How cloud computing is helping bring AI to hospitals worldwide
What do you know about cloud computing and its role in healthcare settings? In this article, Sham Sokka, Chief Operating and Technology Officer, DeepHealth explores how cloud computing is helping hospitals to adopt new AI technologies that enhance patient care.
DeepHealth and Incepto announce strategic partnership to expand access to AI-powered medical imaging
Vienna, Austria, Feb. 28, 2024 – Today, DeepHealth, one of the leading providers of radiology informatics and AI solutions, and Incepto, Europe's leading platform for artificial intelligence (AI) solutions applied to medical imaging, announced they are partnering to deliver expanded access to DeepHealth clinical AI and radiology informatics software. The announcement took place at the European Congress of Radiology (ECR 2024) in Vienna, Austria.
Disclaimers:
DeepHealth Brain is manufactured as Quantib ND by Quantib BV for DeepHealth Inc.
Not all products and functionalities are commercially available in all countries. For clearance and commercial
availability in your geography of functionalities listed and compatibility with other systems, please contact us.